Participating Faculty: Improving Outcomes of Restless Legs Syndrome: Considerations for Managed Care-A Clinician and Payer Perspective Series-Part III

November 30, 2012
Mark J. Buchfuhrer, MD

Supplements and Featured Publications, Improving Outcomes for Restless Legs Syndrome: Considerations for Managed Care—A Clinician and Pay, Volume 18, Issue 12 Suppl

This supplement to The American Journal of Managed Care provides an overview of the clinical and economic burden of restless legs syndrome (RLS); describes challenges in the diagnosis and treatment of RLS; and discusses opportunities for managed care organizations to enhance the recognition and treatment of RLS, to improve outcomes for patients with RLS.This supplement was supported by UCB, Inc.

Faculty

Mark J. Buchfuhrer, MD

Consulting Assistant Professor

Department of Psychiatry and Behavioral Sciences

Stanford School of Medicine

Stanford, California

Disclosures

The faculty reports relationships with the following organizations:

Mark J. Buchfuhrer, MD

Advisory boards: Impax Laboratories, Inc; UCB, Inc

Lectureship fees: GlaxoSmithKline; UCB, Inc

Meeting/conference attendance: GlaxoSmithKline; UCB, Inc

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.